Globus Medical, Inc. (NYSE:GMED) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET
Company Participants
Brian Kearns - SVP, Business Development & IR
Daniel Scavilla - President, CEO & Director
Keith Pfeil - SVP & CFO
Conference Call Participants
Shagun Chadha - RBC Capital Markets
Vikramjeet Chopra - Wells Fargo Securities
Richard Newitter - Truist Securities
David Saxon - Needham & Company
Jason Wittes - Loop Capital Markets
Craig Bijou - Bank of America Merrill Lynch
Andrew Ranieri - Morgan Stanley
Ryan Zimmerman - BTIG
Kyle Rose - Canaccord Genuity
David Turkaly - JMP Securities
Operator
Welcome to the Globus Medical Second Quarter 2022 Earnings Call. [Operator Instructions]. Please be advised that today's conference call is being recorded.
I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations. Mr. Kearns, please go ahead.
Brian Kearns
Thank you, Hope, and thank you, everyone, for being with us today. Joining today's call from Globus Medical will be Dan Scavilla, President and Chief Executive Officer; and Keith Pfeil, Senior Vice President and Chief Financial Officer. This review is being made available via webcast, accessible through the Investor Relations section of the Globus Medical website at www.globusmedical.com.
Before we begin, let me remind you that some of the statements made during this review are or may be considered forward-looking statements. Our Form 10-K for the 2021 fiscal year and our subsequent filings with the Securities and Exchange Commission identify certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today. Our SEC filings, including the 10-K, are available on our website. We do not undertake to update any forward-looking statements as a result of new information or future events or developments.
Our discussion today will also include certain financial measures that are not calculated in accordance with generally accepted accounting principles or GAAP. We believe these non-GAAP financial measures provide additional information pertinent to our business performance. These non-GAAP financial measures should not be considered replacements for and should be read together with the most directly comparable GAAP financial measures. Reconciliations to the most directly comparable GAAP measures are available on the schedules accompanying the press release and on the Investor Relations section of the Globus Medical website.
With that, I'll now turn the call over to Dan Scavilla, our President and CEO.
Daniel Scavilla